These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 22054058)

  • 1. Synthesis of monomeric derivatives to probe memoquin's bivalent interactions.
    Bolognesi ML; Chiriano G; Bartolini M; Mancini F; Bottegoni G; Maestri V; Czvitkovich S; Windisch M; Cavalli A; Minarini A; Rosini M; Tumiatti V; Andrisano V; Melchiorre C
    J Med Chem; 2011 Dec; 54(24):8299-304. PubMed ID: 22054058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benzofuran-based hybrid compounds for the inhibition of cholinesterase activity, beta amyloid aggregation, and abeta neurotoxicity.
    Rizzo S; Rivière C; Piazzi L; Bisi A; Gobbi S; Bartolini M; Andrisano V; Morroni F; Tarozzi A; Monti JP; Rampa A
    J Med Chem; 2008 May; 51(10):2883-6. PubMed ID: 18419109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-activity relationships of memoquin: Influence of the chain chirality in the multi-target mechanism of action.
    Bolognesi ML; Bartolini M; Rosini M; Andrisano V; Melchiorre C
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4312-5. PubMed ID: 19505825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multitargeted drugs discovery: balancing anti-amyloid and anticholinesterase capacity in a single chemical entity.
    Bolognesi ML; Bartolini M; Tarozzi A; Morroni F; Lizzi F; Milelli A; Minarini A; Rosini M; Hrelia P; Andrisano V; Melchiorre C
    Bioorg Med Chem Lett; 2011 May; 21(9):2655-8. PubMed ID: 21236667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholinesterase inhibitors: xanthostigmine derivatives blocking the acetylcholinesterase-induced beta-amyloid aggregation.
    Belluti F; Rampa A; Piazzi L; Bisi A; Gobbi S; Bartolini M; Andrisano V; Cavalli A; Recanatini M; Valenti P
    J Med Chem; 2005 Jun; 48(13):4444-56. PubMed ID: 15974596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, in vitro assay, and molecular modeling of new piperidine derivatives having dual inhibitory potency against acetylcholinesterase and Abeta1-42 aggregation for Alzheimer's disease therapeutics.
    Kwon YE; Park JY; No KT; Shin JH; Lee SK; Eun JS; Yang JH; Shin TY; Kim DK; Chae BS; Leem JY; Kim KH
    Bioorg Med Chem; 2007 Oct; 15(20):6596-607. PubMed ID: 17681794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The bivalent ligand approach as a tool for improving the in vitro anti-Alzheimer multitarget profile of dimebon.
    Rosini M; Simoni E; Bartolini M; Soriano E; Marco-Contelles J; Andrisano V; Monti B; Windisch M; Hutter-Paier B; McClymont DW; Mellor IR; Bolognesi ML
    ChemMedChem; 2013 Aug; 8(8):1276-81. PubMed ID: 23824986
    [No Abstract]   [Full Text] [Related]  

  • 8. Synthesis, biological evaluation and molecular modeling of novel triazole-containing berberine derivatives as acetylcholinesterase and β-amyloid aggregation inhibitors.
    Shi A; Huang L; Lu C; He F; Li X
    Bioorg Med Chem; 2011 Apr; 19(7):2298-305. PubMed ID: 21397508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benzophenone-based derivatives: a novel series of potent and selective dual inhibitors of acetylcholinesterase and acetylcholinesterase-induced beta-amyloid aggregation.
    Belluti F; Bartolini M; Bottegoni G; Bisi A; Cavalli A; Andrisano V; Rampa A
    Eur J Med Chem; 2011 May; 46(5):1682-93. PubMed ID: 21397996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New tacrine-4-oxo-4H-chromene hybrids as multifunctional agents for the treatment of Alzheimer's disease, with cholinergic, antioxidant, and β-amyloid-reducing properties.
    Fernández-Bachiller MI; Pérez C; Monjas L; Rademann J; Rodríguez-Franco MI
    J Med Chem; 2012 Feb; 55(3):1303-17. PubMed ID: 22243648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, biological evaluation, and molecular modeling of donepezil and N-[(5-(benzyloxy)-1-methyl-1H-indol-2-yl)methyl]-N-methylprop-2-yn-1-amine hybrids as new multipotent cholinesterase/monoamine oxidase inhibitors for the treatment of Alzheimer's disease.
    Bolea I; Juárez-Jiménez J; de Los Ríos C; Chioua M; Pouplana R; Luque FJ; Unzeta M; Marco-Contelles J; Samadi A
    J Med Chem; 2011 Dec; 54(24):8251-70. PubMed ID: 22023459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple Ligands Targeting Cholinesterases and β-Amyloid: Synthesis, Biological Evaluation of Heterodimeric Compounds with Benzylamine Pharmacophore.
    Szałaj N; Bajda M; Dudek K; Brus B; Gobec S; Malawska B
    Arch Pharm (Weinheim); 2015 Aug; 348(8):556-63. PubMed ID: 26032855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Syntheses and characterization of novel oxoisoaporphine derivatives as dual inhibitors for cholinesterases and amyloid beta aggregation.
    Li YP; Ning FX; Yang MB; Li YC; Nie MH; Ou TM; Tan JH; Huang SL; Li D; Gu LQ; Huang ZS
    Eur J Med Chem; 2011 May; 46(5):1572-81. PubMed ID: 21367493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 3-(4-[[Benzyl(methyl)amino]methyl]phenyl)-6,7-dimethoxy-2H-2-chromenone (AP2238) inhibits both acetylcholinesterase and acetylcholinesterase-induced beta-amyloid aggregation: a dual function lead for Alzheimer's disease therapy.
    Piazzi L; Rampa A; Bisi A; Gobbi S; Belluti F; Cavalli A; Bartolini M; Andrisano V; Valenti P; Recanatini M
    J Med Chem; 2003 Jun; 46(12):2279-82. PubMed ID: 12773032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis, and bioevaluation of benzamides: novel acetylcholinesterase inhibitors with multi-functions on butylcholinesterase, Aβ aggregation, and β-secretase.
    Peng DY; Sun Q; Zhu XL; Lin HY; Chen Q; Yu NX; Yang WC; Yang GF
    Bioorg Med Chem; 2012 Nov; 20(22):6739-50. PubMed ID: 23041347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and evaluation of 7,8-dehydrorutaecarpine derivatives as potential multifunctional agents for the treatment of Alzheimer's disease.
    He Y; Yao PF; Chen SB; Huang ZH; Huang SL; Tan JH; Li D; Gu LQ; Huang ZS
    Eur J Med Chem; 2013 May; 63():299-312. PubMed ID: 23501115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis and evaluation of flavonoid derivatives as potential multifunctional acetylcholinesterase inhibitors against Alzheimer's disease.
    Li RS; Wang XB; Hu XJ; Kong LY
    Bioorg Med Chem Lett; 2013 May; 23(9):2636-41. PubMed ID: 23511019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel class of quinone-bearing polyamines as multi-target-directed ligands to combat Alzheimer's disease.
    Bolognesi ML; Banzi R; Bartolini M; Cavalli A; Tarozzi A; Andrisano V; Minarini A; Rosini M; Tumiatti V; Bergamini C; Fato R; Lenaz G; Hrelia P; Cattaneo A; Recanatini M; Melchiorre C
    J Med Chem; 2007 Oct; 50(20):4882-97. PubMed ID: 17850125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Searching for the Multi-Target-Directed Ligands against Alzheimer's disease: discovery of quinoxaline-based hybrid compounds with AChE, H₃R and BACE 1 inhibitory activities.
    Huang W; Tang L; Shi Y; Huang S; Xu L; Sheng R; Wu P; Li J; Zhou N; Hu Y
    Bioorg Med Chem; 2011 Dec; 19(23):7158-67. PubMed ID: 22019465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis and biological evaluation of novel dual inhibitors of acetylcholinesterase and beta-secretase.
    Zhu Y; Xiao K; Ma L; Xiong B; Fu Y; Yu H; Wang W; Wang X; Hu D; Peng H; Li J; Gong Q; Chai Q; Tang X; Zhang H; Li J; Shen J
    Bioorg Med Chem; 2009 Feb; 17(4):1600-13. PubMed ID: 19162488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.